Although there are no studies on the specific repair mechanisms and therapeutic effects of CD200-CD200R in poststroke inflammation injury, CD200R can still be considered a high potential target in the study of stroke immunotherapy. This evidence concerns the gene CD200R1 and stroke disorder.